SIMILAR PATTERNS OF AMINO ACIDS FOR 6C9Z_A_VOGA701_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ILE A 249MET A 321ARG A 400ASP A 416PHE A 449 | NoneBOG A2000 ( 4.0A)BOG A2000 (-3.1A)BOG A2000 (-3.0A)None | 0.94A | 6c9zA-2g3nA:41.5 | 6c9zA-2g3nA:27.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 11 | TYR A 184ILE A 213ILE A 249TRP A 284ASP A 320MET A 321ARG A 400TRP A 413ASP A 416PHE A 449HIS A 480 | BOG A2000 (-4.5A)NoneNoneNoneNoneBOG A2000 ( 4.0A)BOG A2000 (-3.1A)NoneBOG A2000 (-3.0A)NoneNone | 0.59A | 6c9zA-2g3nA:41.5 | 6c9zA-2g3nA:27.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 8 | TYR A 184ILE A 213ILE A 249TRP A 284TRP A 318TRP A 413PHE A 449HIS A 480 | BOG A2000 (-4.5A)NoneNoneNoneNoneNoneNoneNone | 1.05A | 6c9zA-2g3nA:41.5 | 6c9zA-2g3nA:27.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2uyo | HYPOTHETICAL PROTEINML2640 (Mycobacteriumleprae) |
PF04072(LCM) | 5 | TYR A 118ILE A 108ASP A 114ARG A 25ASP A 38 | None | 1.31A | 6c9zA-2uyoA:undetectable | 6c9zA-2uyoA:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) |
PF01055(Glyco_hydro_31) | 7 | ASP A 553MET A 554ARG A 649TRP A 662ASP A 665PHE A 698HIS A 731 | QPS A1050 (-3.1A)QPS A1050 (-3.1A)QPS A1050 (-3.2A)QPS A1050 (-4.6A)QPS A1050 (-2.7A)QPS A1050 (-4.3A)QPS A1050 (-4.3A) | 0.36A | 6c9zA-2x2iA:30.3 | 6c9zA-2x2iA:24.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | ASP A 582ARG A 642TRP A 656ASP A 659PHE A 692HIS A 740 | None | 0.48A | 6c9zA-2xvgA:32.4 | 6c9zA-2xvgA:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | TRP A 471ASP A 582ARG A 642TRP A 656ASP A 659 | EDO A1997 ( 4.5A)NoneNoneNoneNone | 1.34A | 6c9zA-2xvgA:32.4 | 6c9zA-2xvgA:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 5 | ILE A 328MET A 444ASP A 542PHE A 575HIS A 600 | 3CU A1001 ( 3.9A)3CU A1001 ( 3.9A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 1.50A | 6c9zA-3cttA:34.3 | 6c9zA-3cttA:25.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 5 | ILE A 364MET A 444ARG A 526ASP A 542PHE A 575 | 3CU A1001 (-4.5A)3CU A1001 ( 3.9A)3CU A1001 ( 3.5A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A) | 1.00A | 6c9zA-3cttA:34.3 | 6c9zA-3cttA:25.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 11 | TYR A 299ILE A 328ILE A 364TRP A 406ASP A 443MET A 444ARG A 526TRP A 539ASP A 542PHE A 575HIS A 600 | 3CU A1001 (-3.6A)3CU A1001 ( 3.9A)3CU A1001 (-4.5A)None3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 ( 3.5A)3CU A1001 (-4.6A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 0.53A | 6c9zA-3cttA:34.3 | 6c9zA-3cttA:25.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 7 | TYR A 299ILE A 328ILE A 364TRP A 406TRP A 441PHE A 575HIS A 600 | 3CU A1001 (-3.6A)3CU A1001 ( 3.9A)3CU A1001 (-4.5A)None3CU A1001 (-4.9A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 1.03A | 6c9zA-3cttA:34.3 | 6c9zA-3cttA:25.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3j9d | OUTER CAPSID PROTEINVP2 (Bluetonguevirus) |
PF00898(Orbi_VP2) | 5 | ILE A 176ILE A 670ASP A 669ARG A 695ASP A 111 | None | 1.30A | 6c9zA-3j9dA:undetectable | 6c9zA-3j9dA:22.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ILE A 356ILE A 392TRP A 435ASP A 472MET A 473ARG A 555TRP A 568ASP A 571PHE A 604HIS A 629 | TRS A6001 ( 4.0A)NoneTRS A6001 ( 4.6A)TRS A6001 (-3.2A)TRS A6001 ( 3.7A)TRS A6001 ( 4.6A)NoneTRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 0.37A | 6c9zA-3lppA:36.0 | 6c9zA-3lppA:24.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 7 | ILE A 356ILE A 392TRP A 435TRP A 470TRP A 568PHE A 604HIS A 629 | TRS A6001 ( 4.0A)NoneTRS A6001 ( 4.6A)NoneNoneTRS A6001 (-4.4A)TRS A6001 (-4.2A) | 0.94A | 6c9zA-3lppA:36.0 | 6c9zA-3lppA:24.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 5 | ILE A 356MET A 473ASP A 571PHE A 604HIS A 629 | TRS A6001 ( 4.0A)TRS A6001 ( 3.7A)TRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 1.46A | 6c9zA-3lppA:36.0 | 6c9zA-3lppA:24.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 10 | ILE A 198ILE A 234TRP A 271TRP A 305MET A 308ARG A 404TRP A 417ASP A 420PHE A 453HIS A 478 | ACR A 664 (-3.5A)NoneACR A 664 (-4.6A)NoneACR A 664 ( 3.8A)ACR A 664 (-4.0A)ACR A 664 (-4.6A)ACR A 664 (-2.8A)ACR A 664 (-4.4A)ACR A 664 (-4.2A) | 0.24A | 6c9zA-3pocA:66.6 | 6c9zA-3pocA:99.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ILE A 198MET A 308ARG A 404ASP A 420PHE A 453HIS A 478 | ACR A 664 (-3.5A)ACR A 664 ( 3.8A)ACR A 664 (-4.0A)ACR A 664 (-2.8A)ACR A 664 (-4.4A)ACR A 664 (-4.2A) | 1.27A | 6c9zA-3pocA:66.6 | 6c9zA-3pocA:99.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 5 | ILE A1280MET A1421ASP A1526PHE A1559HIS A1584 | ACR A 1 (-4.1A)ACR A 1 (-3.5A)ACR A 1 (-2.8A)ACR A 1 (-4.3A)ACR A 1 (-3.9A) | 1.38A | 6c9zA-3topA:33.4 | 6c9zA-3topA:24.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 11 | TYR A1251ILE A1280ILE A1315TRP A1355ASP A1420MET A1421ARG A1510TRP A1523ASP A1526PHE A1559HIS A1584 | ACR A 1 ( 4.1A)ACR A 1 (-4.1A)NoneACR A 1 (-4.4A)ACR A 1 (-3.6A)ACR A 1 (-3.5A)ACR A 1 (-2.9A)ACR A 1 (-4.5A)ACR A 1 (-2.8A)ACR A 1 (-4.3A)ACR A 1 (-3.9A) | 0.42A | 6c9zA-3topA:33.4 | 6c9zA-3topA:24.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 7 | TYR A1251ILE A1280ILE A1315TRP A1355TRP A1418PHE A1559HIS A1584 | ACR A 1 ( 4.1A)ACR A 1 (-4.1A)NoneACR A 1 (-4.4A)NoneACR A 1 (-4.3A)ACR A 1 (-3.9A) | 0.96A | 6c9zA-3topA:33.4 | 6c9zA-3topA:24.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 5 | TYR A1251TRP A1355MET A1421ASP A1526PHE A1560 | ACR A 1 ( 4.1A)ACR A 1 (-4.4A)ACR A 1 (-3.5A)ACR A 1 (-2.8A)ACR A 1 (-3.7A) | 1.44A | 6c9zA-3topA:33.4 | 6c9zA-3topA:24.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 10 | ILE A 358ILE A 396TRP A 432ASP A 469MET A 470ARG A 552TRP A 565ASP A 568PHE A 601HIS A 626 | ACR A1001 (-3.6A)ACR A1001 (-4.9A)ACR A1001 ( 4.6A)ACR A1001 (-3.2A)ACR A1001 (-3.3A)ACR A1001 (-3.0A)ACR A1001 (-4.8A)ACR A1001 (-2.7A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 0.36A | 6c9zA-3welA:35.9 | 6c9zA-3welA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 7 | ILE A 358ILE A 396TRP A 432TRP A 467TRP A 565PHE A 601HIS A 626 | ACR A1001 (-3.6A)ACR A1001 (-4.9A)ACR A1001 ( 4.6A)NoneACR A1001 (-4.8A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 0.96A | 6c9zA-3welA:35.9 | 6c9zA-3welA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 5 | ILE A 358MET A 470ASP A 568PHE A 601HIS A 626 | ACR A1001 (-3.6A)ACR A1001 (-3.3A)ACR A1001 (-2.7A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 1.43A | 6c9zA-3welA:35.9 | 6c9zA-3welA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 5 | ILE A 396MET A 470ARG A 552ASP A 568PHE A 601 | ACR A1001 (-4.9A)ACR A1001 (-3.3A)ACR A1001 (-3.0A)ACR A1001 (-2.7A)ACR A1001 (-4.3A) | 0.89A | 6c9zA-3welA:35.9 | 6c9zA-3welA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 7 | ILE A 341ASP A 412ARG A 463TRP A 477ASP A 480PHE A 513HIS A 540 | None | 0.48A | 6c9zA-4b9yA:34.3 | 6c9zA-4b9yA:24.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djw | ALPHA-GLUCOSIDASE II (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 5 | TRP A 285ASP A 321ARG A 385ASP A 401PHE A 434 | None | 1.20A | 6c9zA-5djwA:36.8 | 6c9zA-5djwA:27.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 10 | ILE A 444ILE A 480TRP A 517ASP A 556MET A 557ARG A 617TRP A 630ASP A 633PHE A 666HIS A 691 | TRS A1001 ( 4.1A)NoneTRS A1001 ( 4.9A)TRS A1001 (-3.2A)TRS A1001 (-3.5A)TRS A1001 (-4.0A)NoneTRS A1001 (-2.8A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 0.36A | 6c9zA-5dkxA:32.9 | 6c9zA-5dkxA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 7 | ILE A 444ILE A 480TRP A 517TRP A 554TRP A 630PHE A 666HIS A 691 | TRS A1001 ( 4.1A)NoneTRS A1001 ( 4.9A)TRS A1001 (-4.9A)NoneTRS A1001 (-4.5A)TRS A1001 (-4.0A) | 0.89A | 6c9zA-5dkxA:32.9 | 6c9zA-5dkxA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7c | ALPHA-GLUCOSIDASE (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ASP A 460ARG A 507TRP A 520ASP A 523PHE A 556HIS A 588 | None | 0.26A | 6c9zA-5f7cA:32.0 | 6c9zA-5f7cA:23.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7s | GLYCOSIDE HYDROLASEFAMILY 31 (Trueperellapyogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ASP A 467ARG A 516TRP A 529ASP A 532PHE A 565HIS A 591 | CA A 805 (-2.9A) CA A 805 ( 4.6A)None CA A 805 ( 4.6A)NoneNone | 0.49A | 6c9zA-5f7sA:34.5 | 6c9zA-5f7sA:23.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7u | CYCLOALTERNAN-FORMING ENZYME (Listeriamonocytogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF16990(CBM_35) | 5 | ARG A 614TRP A 627ASP A 630PHE A 663HIS A 689 | GLC A1116 (-2.8A)GLC A1117 (-4.6A)GLC A1117 (-2.7A)GLC A1116 (-4.6A)GLC A1117 (-4.1A) | 0.60A | 6c9zA-5f7uA:13.9 | 6c9zA-5f7uA:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 10 | ILE A 452ILE A 488TRP A 525ASP A 564MET A 565ARG A 624TRP A 637ASP A 640PHE A 673HIS A 698 | 5GF A1021 (-3.6A)None5GF A1021 (-3.7A)5GF A1021 (-2.1A)5GF A1021 (-2.6A)5GF A1021 (-3.4A)5GF A1021 ( 4.6A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 0.46A | 6c9zA-5hjrA:35.4 | 6c9zA-5hjrA:25.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 7 | ILE A 452ILE A 488TRP A 525TRP A 562TRP A 637PHE A 673HIS A 698 | 5GF A1021 (-3.6A)None5GF A1021 (-3.7A)5GF A1021 (-4.6A)5GF A1021 ( 4.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 0.98A | 6c9zA-5hjrA:35.4 | 6c9zA-5hjrA:25.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 7 | ILE A 488MET A 565ARG A 624TRP A 637ASP A 640PHE A 673HIS A 698 | None5GF A1021 (-2.6A)5GF A1021 (-3.4A)5GF A1021 ( 4.6A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 1.02A | 6c9zA-5hjrA:35.4 | 6c9zA-5hjrA:25.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | ASP A 553ARG A 613TRP A 627ASP A 630PHE A 663HIS A 709 | EDO A1008 (-2.7A)EDO A1008 (-4.6A)NoneEDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 0.38A | 6c9zA-5jouA:32.1 | 6c9zA-5jouA:23.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | TRP A 442ASP A 553ARG A 613TRP A 627ASP A 630 | EDO A1008 (-3.7A)EDO A1008 (-2.7A)EDO A1008 (-4.6A)NoneEDO A1008 (-3.0A) | 1.39A | 6c9zA-5jouA:32.1 | 6c9zA-5jouA:23.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 5 | ILE A 441MET A 519ARG A 600ASP A 616PHE A 649 | ACR A1015 (-4.3A)ACR A1015 (-3.3A)ACR A1015 (-3.1A)ACR A1015 (-2.7A)ACR A1015 (-4.3A) | 0.86A | 6c9zA-5nn8A:34.9 | 6c9zA-5nn8A:24.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 9 | ILE A 441TRP A 481ASP A 518MET A 519ARG A 600TRP A 613ASP A 616PHE A 649HIS A 674 | ACR A1015 (-4.3A)ACR A1015 ( 4.6A)ACR A1015 (-3.1A)ACR A1015 (-3.3A)ACR A1015 (-3.1A)ACR A1015 (-4.8A)ACR A1015 (-2.7A)ACR A1015 (-4.3A)ACR A1015 (-4.0A) | 0.35A | 6c9zA-5nn8A:34.9 | 6c9zA-5nn8A:24.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 5 | ILE A 441TRP A 481TRP A 516PHE A 649HIS A 674 | ACR A1015 (-4.3A)ACR A1015 ( 4.6A)NoneACR A1015 (-4.3A)ACR A1015 (-4.0A) | 0.99A | 6c9zA-5nn8A:34.9 | 6c9zA-5nn8A:24.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x3j | GLYCOSIDE HYDROLASEFAMILY 31 (Kribbellaflavida) |
no annotation | 5 | ARG A 500TRP A 513ASP A 516PHE A 549HIS A 575 | GLC A 819 ( 2.9A)GLC A 822 ( 4.6A)GLC A 822 ( 2.8A)GLC A 822 ( 4.8A)GLC A 822 ( 4.0A) | 0.54A | 6c9zA-5x3jA:30.2 | 6c9zA-5x3jA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x7s | GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE (Paenibacillussp. 598K) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF16990(CBM_35)PF17137(DUF5110) | 6 | ASP A 429ARG A 474TRP A 488ASP A 491PHE A 533HIS A 565 | None | 0.37A | 6c9zA-5x7sA:17.2 | 6c9zA-5x7sA:19.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5y10 | MEMBRANEGLYCOPROTEINPOLYPROTEIN (SFTSphlebovirus) |
PF07243(Phlebovirus_G1) | 5 | TYR C 44ILE C 25ASP C 52ARG C 77ASP C 100 | None | 1.50A | 6c9zA-5y10C:undetectable | 6c9zA-5y10C:17.61 |